Beckman Coulter Gets 510(k) for Test to Distinguish Bacterial, Viral Infections

Beckman Coulter, a Danaher subsidiary, received FDA 510(k) clearance for a rapid test that helps clinicians distinguish between bacterial and viral infections.

This Wire brief sits within Fusion42's coverage of Diagnostics, and 6 sources have reported it between 3 Nov 2026 and 4 Nov 2026.